#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperoxaluria Myelin oligodendrocyte glycoprotein antibody-associated disease Autoinflammation with infantile enterocolitis Diffuse large B-cell lymphoma refractory Pyruvate kinase deficiency anaemia Rectal cancer Colon cancer Synovial sarcoma recurrent Autoimmune haemolytic anaemia Extra-osseous Ewing's sarcoma metastatic Dermatomyositis Factor VIII deficiency Pancreatic carcinoma metastatic Adenocarcinoma pancreas Cerebral haemorrhage More trials…

    Learn about Rare Diseases

    Malignant fibrous histiocytoma – Trials in Disease Ornithine transcarbamoylase deficiency – Basic Information Progressive multifocal leukoencephalopathy Primary biliary cholangitis – Life with Disease Glycogen storage disease type V – Trials in Disease Castleman’s disease – Diagnostics Hereditary neuropathic amyloidosis – Trials in Disease Hereditary motor and sensory neuropathy – Treatment Ewing’s sarcoma metastatic – Basic Information Mantle cell lymphoma stage III More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elvn-002-1 A49 Anitocabtagene Autoleucel Remestemcel Amy109 Dl-Alpha Tocopherol Acetate Dupilumab Rifamycin Sodium Damoctocog Alfa Pegol Mycophenolic Acid Gandotinib Naloxone Navitoclax Apadamtase Alfa SOFOSBUVIR IHMA-2121771-2 Quetiapine Rhh646 Ethanol, Anhydrous Melatonin More therapies…

    Learn about Your Condition

    Sleep disorder Juvenile idiopathic arthritis Kaposi's sarcoma Axial spondyloarthritis Giant cell arteritis Lipid metabolism disorder Cardiac failure chronic Brain stem glioma Fabry's disease Poor quality sleep Malignant melanoma stage IV Bacterial infection Habitual abortion Metabolic surgery Large cell lung cancer stage 0 More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mykovm Zqvajorn Kehbt 2vc Dofwjceig 4tkvq Htflubu

Want to learn more about this study or check if you can participate? Contact us.

  • Study comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • RO7795081
    • Semaglutide
    Hungary Poland Spain

  • Study of Tibulizumab to Treat Adults with Hidradenitis Suppurativa

    Not recruiting

    2 1
    Investigated Diseases:
    • Hidradenitis
    Germany Hungary Poland Spain

  • Long-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Sonelokimab
    Belgium Bulgaria Czechia France Germany Hungary +7

  • Study of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypercholesterolaemia
    Bulgaria Czechia Germany Hungary Poland Slovakia +1

  • Study of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)

    Not recruiting

    3 1
    Bulgaria Czechia Denmark Finland France Germany +6

  • Study of Ruxolitinib Cream for Children and Adolescents Ages 6-17 with Moderate Atopic Dermatitis Who Did Not Respond Well to Standard Treatments

    Not recruiting

    3 1
    Investigated Drugs:
    • Ruxolitinib
    Belgium France Germany Hungary Italy Poland +1

  • Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Risankizumab
    • Vedolizumab
    Austria Bulgaria Croatia Czechia Estonia Finland +14

  • Study on the Effectiveness and Safety of EYE103 Compared to Ranibizumab for Patients with Diabetic Macular Edema

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Diabetic retinal oedema
    Investigated Drugs:
    • Eye103
    • Fluorescein Sodium
    • Ranibizumab
    Austria Croatia Czechia France Germany Hungary +6

  • Study on the Effects of EVO756 in Adults with Moderate to Severe Chronic Spontaneous Urticaria

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Investigated Drugs:
    • Placebo
    Bulgaria Germany Hungary Italy Poland Spain

  • Study on the Safety and Effectiveness of Clesrovimab and Palivizumab for Preventing Severe RSV in Infants and Children at High Risk

    Not recruiting

    3 1 1
    Investigated Drugs:
    • CLESROVIMAB
    • Palivizumab
    • Sodium Chloride
    Czechia Finland France Germany Greece Hungary +3
Previous Page
1 … 24 25 26 27 28 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!